title: [Antimicrobial therapy in granulopenic patients with malignant hematologic diseases (author's transl)].
abstract: Rational antimicrobial therapy in neutropenic patients includes early empiric therapy with combinations of antibiotics active in vitro against the causal pathogen. The duration of therapy is to be adapted to the clinical response. In patients who do not respond to antimicrobial therapy, transfusion of granulocytes and empiric use of antifungal drugs should be considered.
mesh_terms: D000380:Agranulocytosis / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000150:complications*; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents
vernacular_title: Antibiotherapie curative des infections chez les malades atteints d'hemopathies.